0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover408.79%IV-67.15%PremiumAug 16, 2024Expiry Date5.11Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9430Delta0.0143Gamma1.35Leverage Ratio-0.0191Theta0.0012Rho1.27Eff Leverage0.0022Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$